Pharma
India in a first sets fees for medical device testing and certification, moves away from market-driven mode
India is introducing a standardized fee structure for medical device testing to replace inconsistent market rates and enhance manufacturing traceability.
2 min read13 Apr 2026Big pharma is turning to China for the newest drug ideas
China’s biotechs are faster and have lower costs, and its drug research threatens to soon overtake the West’s
6 min read11 Apr 2026India looks to bar cough syrup for babies under two
This regulatory tightening follows alarm over discovery of toxic industrial solvents, including diethylene glycol (DEG) and ethylene glycol (EG), in liquid oral formulations, which could lead to acute kidney failure and even death, thereby denting India’s image as the ‘pharmacy of the world’.
4 min read11 Apr 2026US sales may drag pharma companies’ Q4, even as India holds up
Cipla, Dr Reddy’s Laboratories, and Zydus Lifesciences are among the most affected by the US sales decline.
2 min read10 Apr 2026India plans to restrict vaccine and biologics testing to government labs to maintain quality standards
With CDSCO restricting vaccine and biologic testing to government labs, experts weigh the benefits of rigorous control against potential delays for a sector crucial to global healthcare supply.
4 min read10 Apr 2026Efforts to raise production of pharma-grade methanol underway, but logistics issues persist, says official
The pharmaceutical sector faces a critical methanol shortage due to logistical hurdles in transporting domestic supplies from remote regions. The government is now coordinating efforts to prioritize chemical allocations and stabilize life-saving drug production.
2 min read9 Apr 2026Lupin shares to be in focus on Thursday as USFDA approves Dapagliflozin and Metformin tablets
Lupin's shares are expected to attract investor attention as the company received U.S. FDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets.
1 min read8 Apr 2026Aurobindo Pharma declares buyback of shares at ₹1475. Size, record date, other details
Aurobindo Pharma has declared buyback of up to 54,23,728 company shares aggregating up to ₹ ₹800 crore
2 min read6 Apr 2026Govt steps in after LPG diversion triggers near-crisis in pharma supply chain
The move choked the production of a key solvent— isopropyl alcohol or IPA—used in essential medicines and life-saving drugs, and forced top drugmakers to warn of disruptions to medicine supplies, according to documents reviewed by Mint and three people familiar with the matter.
5 min read4 Apr 2026Sun Pharma share price in focus on Monday after Trump's tariff announcement
Sun Pharma shares will be in focus on April 6 due to President Trump's new executive order imposing 100% tariffs on imported branded drugs unless companies lower prices or produce domestically. Jefferies reports that Sun Pharma may only face up to 15% tariffs on its innovative products.
2 min read3 Apr 2026